Author : Effendy A. Sumardja

Summary : Conclusions: Different research projects, field tests and larger scale introductions needing risk management will exhibit variety dependent upon the biological features of the GMO, the specific risk(s) posed, and the features that affect the success of containment (e.g. scale, duration, project siting). Therefore, the key required for general risk management capacities as outlined in the Cartagena Protocol, is the developing of a strong working knowledge relating to the application of risk management tools to different biotechnology sectors across a wide range of organisms and environmental conditions. Several mechanisms have recently been proposed to facilitate this translation of expanding biosafety experience into effective national policies for the mitigation of the risks associated with GMO introduction and widespread use. International databases are important sources of information for risk assessment and risk management, because they provide detailed knowledge based on experience gained relating to organisms with novel traits, and aid in the development of accurate predictive models. Biosafety Clearing Houses could also be established in each country to further facilitate the coordinated treatment of biotechnology issues as they arise, as well as facilitating beneficial communication both within countries and internationally. It is hoped that this coordinated processing of complex data arising from biosafety and GMO risk assessment will be presented in a format that will facilitate the development of appropriate biotechnology and risk management policies across the Southeast Asia region. Successful development and implementation of effective national biosafety policies will only be made possible through collaboration between stakeholders. Biosafety more than any other field, requires close integration and dialogue between scientists and policy makers to ensure the achievement of objectives.